NCI employees can’t publish information on these topics without special approval
This story was originally published by ProPublica.
Employees at the National Cancer Institute, which is part of the National Institutes of Health, received internal guidance last week to flag manuscripts, presentations or other communications for scrutiny if they addressed “controversial, high profile, or sensitive” topics. Among the 23 hot-button issues, according to internal records reviewed by ProPublica: vaccines, fluoride, peanut allergies, autism.
While it’s not uncommon for the cancer institute to outline a couple of administration priorities, the scope and scale of the list is unprecedented and highly unusual, said six employees who spoke on the condition of anonymity because they were not authorized to comment publicly. All materials must be reviewed by an institute “clearance team,” according to the records, and could be examined by officials at the NIH or its umbrella agency, the US Department of Health and Human Services.
